18 results for author:"Graubert T.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (37)
| Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Graubert T.A., Shen D., Ding L., Okeyo-Owuor T., Lunn C.L., Shao J., Krysiak K., Harris C.C., Koboldt D.C., Larson D.E. et al. Nat. Genet. 44:53-57(2012) · Mapped (4) |
| Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Walter M.J., Ding L., Shen D., Shao J., Grillot M., McLellan M., Fulton R., Schmidt H., Kalicki-Veizer J., O'Laughlin M. et al. Leukemia 25:1153-1158(2011) · Mapped (4) |
| DNMT3A mutations in acute myeloid leukemia. Ley T.J., Ding L., Walter M.J., McLellan M.D., Lamprecht T., Larson D.E., Kandoth C., Payton J.E., Baty J., Welch J. et al. N. Engl. J. Med. 363:2424-2433(2010) · Mapped (6) |
| POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature. Fortier J.M., Payton J.E., Cahan P., Ley T.J., Walter M.J., Graubert T.A. Leukemia 24:950-957(2010) · Mapped (1) |
| Recurring mutations found by sequencing an acute myeloid leukemia genome. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., Koboldt D.C., Fulton R.S., Delehaunty K.D., McGrath S.D. et al. N. Engl. J. Med. 361:1058-1066(2009) · Mapped (9) |
| Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis. Graubert T.A., Payton M.A., Shao J., Walgren R.A., Monahan R.S., Frater J.L., Walshauser M.A., Martin M.G., Kasai Y., Walter M.J. PLoS ONE 4:e4583-e4583(2009) · Mapped (27) |
| DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K., Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M. et al. Nature 456:66-72(2008) · UniProtKB (36) |
| Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic mice. Funk R.K., Maxwell T.J., Izumi M., Edwin D., Kreisel F., Ley T.J., Cheverud J.M., Graubert T.A. Blood 112:1434-1442(2008) · Mapped (3) |
| Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Tomasson M.H., Xiang Z., Walgren R., Zhao Y., Kasai Y., Miner T., Ries R.E., Lubman O., Fremont D.H., McLellan M.D. et al. Blood 111:4797-4808(2008) · Mapped (30) |
| Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. Xiang Z., Zhao Y., Mitaksov V., Fremont D.H., Kasai Y., Molitoris A., Ries R.E., Miner T.L., McLellan M.D., DiPersio J.F. et al. Blood 111:4809-4812(2008) · Mapped (5) |
| Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. Fenske T.S., McMahon C., Edwin D., Jarvis J.C., Cheverud J.M., Minn M., Mathews V., Bogue M.A., Province M.A., McLeod H.L. et al. Cancer Res. 66:5029-5038(2006) · Mapped (130) |
| Roles of Sca-1 in hematopoietic stem/progenitor cell function. Bradfute S.B., Graubert T.A., Goodell M.A. Exp. Hematol. 33:836-843(2005) · Mapped (1) |
| Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice. Fenske T.S., Pengue G., Mathews V., Hanson P.T., Hamm S.E., Riaz N., Graubert T.A. Proc. Natl. Acad. Sci. U.S.A. 101:15184-15189(2004) · Mapped (1) |
| Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Hanson P., Mathews V., Marrus S.H., Graubert T.A. Exp. Hematol. 31:159-167(2003) · Mapped (1) |
| Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Welm B.E., Tepera S.B., Venezia T., Graubert T.A., Rosen J.M., Goodell M.A. Dev. Biol. 245:42-56(2002) · Mapped (1) |
| Characterization of Ly-6M, a novel member of the Ly-6 family of hematopoietic proteins. Patterson J.M.M., Johnson M.H., Zimonjic D.B., Graubert T.A. |
| Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Shresta S., Graubert T.A., Thomas D.A., Raptis S.Z., Ley T.J. Immunity 10:595-605(1999) · Mapped (9) |
| Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. Graubert T.A., DiPersio J.F., Russell J.H., Ley T.J. J. Clin. Invest. 100:904-911(1997) · Mapped (32) |